Description

Dilaudid 8 mg

Dilaudid 8 mg (hydromorphone hydrochloride), a hydrogenated ketone of morphine, is an opioid agonist.

Pills Dilaudid 8 mg Hydromorphone

Also, DILAUDID Tablets are supplied in 2 mg, 4 mg, and 8 mg tablets for oral administration. Therefore, The tablet strengths describe the amount of hydromorphone hydrochloride per tablet.

Hydromorphone 8mg

DILAUDID Oral Solution is supplied as 5mg/5 mL (1 mg/mL) viscous liquid.

The chemical name is 4,5α-epoxy-3-hydroxy-17-methylmorphinan-6-one hydrochloride. Also, The molecular Weight is 321.80. Its molecular formula is C₁₇H₁₉NO₃·HCl, and it has the following chemical structure:

Hydromorphone hydrochloride is a white or almost white crystalline powder that is freely soluble in water. Also, Very slightly soluble in ethanol (96%), and practically insoluble in methylene chloride.

The 2 mg, 4 mg, and 8 mg tablets contain the following inactive ingredients. Lactose anhydrous and magnesium stearate. DILAUDID Tablets may also contain traces of sodium metabisulfite.

Also, The 2 mg tablets contain D&C Red #30 Lake dye, and D&C yellow #10 Lake Dye.

The 4 mg tablets also contain D&C yellow #10 Lake Dye.

Therefore, Each 5 mL (1 teaspoon) of DILAUDID Oral Solution contains 5 mg of hydromorphone hydrochloride. The inactive ingredients are purified water, methylparaben, propylparaben, sucrose, and glycerin. DILAUDID Oral Solution may contain traces of sodium metabisulfite.

Detail Description of Dilaudid for Sale

Hydromorphone is a pure opioid. Therefore, A semi-synthetic hydrogenated ketone derivative of morphine. Available clinically since 1920. Structurally, hydromorphone derives from morphine in the modification of the hydroxyl group. Also, in the carbon 6 to a carbonyl. Therefore, the absence of a double bond between the carbon 7 and 8. Due to these modifications, it presents a very high potency and comparable side effect profile to the parent compound.

Also, Even though hydromorphone does not present a 6-hydroxyl group. Categorized under the family of phenanthrenes. Therefore, considered a chemical under schedule II (medical purposes with high addiction potential).

The first product containing hydromorphone in the form of hydromorphone hydrochloride was developed by Fresenius Kabi USA and FDA approved in 1984.

Dilaudid for Sale, DILAUDID (hydromorphone hydrochloride), a hydrogenated ketone of morphine, is an opioid agonist.

Also, DILAUDID Tablets are supplied in 2 mg, 4 mg, and 8 mg tablets for oral administration. Therefore, The tablet strengths describe the amount of hydromorphone hydrochloride per tablet.

DILAUDID Oral Solution is supplied as 5mg/5 mL (1 mg/mL) viscous liquid.

The chemical name is 4,5α-epoxy-3-hydroxy-17-methylmorphinan-6-one hydrochloride. Also, The molecular Weight is 321.80. Its molecular formula is C₁₇H₁₉NO₃·HCl, and it has the following chemical structure:

So Hydromorphone hydrochloride is a white or almost white crystalline powder that is freely soluble in water. Also, Very slightly soluble in ethanol (96%), and practically insoluble in methylene chloride.

The 2 mg, 4 mg, and 8 mg tablets contain the following inactive ingredients. Lactose anhydrous and magnesium stearate. DILAUDID Tablets may also contain traces of sodium metabisulfite.

Also, The 2 mg tablets contain D&C Red #30 Lake dye, and D&C yellow #10 Lake Dye.

The 4 mg tablets also contain D&C yellow #10 Lake Dye.

Therefore, Each 5 mL (1 teaspoon) of DILAUDID Oral Solution contains 5 mg of hydromorphone hydrochloride. The inactive ingredients are purified water, methylparaben, propylparaben, sucrose, and glycerin. DILAUDID Oral Solution may contain traces of sodium metabisulfite.

Detail Description of Dilaudid for Sale

Hydromorphone is a pure opioid. Therefore, A semi-synthetic hydrogenated ketone derivative of morphine. Available clinically since 1920. Structurally, hydromorphone derives from morphine in the modification of the hydroxyl group. Also, in the carbon 6 to a carbonyl. Therefore, the absence of a double bond between the carbon 7 and 8. Due to these modifications, it presents a very high potency and comparable side effect profile to the parent compound.

Also, Even though hydromorphone does not present a 6-hydroxyl group. Categorized under the family of phenanthrenes. Therefore, considered a chemical under schedule II (medical purposes with high addiction potential).

The first product containing hydromorphone in the form of hydromorphone hydrochloride was developed by Fresenius Kabi USA and FDA approved in 1984.